Literature DB >> 9566601

Blood-brain barrier carrier-mediated transport and brain metabolism of amino acids.

W M Pardridge1.   

Abstract

The transport of neutral amino acids through the brain capillary endothelial wall, which makes up the blood-brain barrier (BBB) in vivo, is an important control point for the overall regulation of cerebral metabolism, including protein synthesis and neurotransmitter production. The Michaelis-Menten kinetics of BBB amino acid transport have been investigated in vivo with the brain uptake index (BUI) technique, and in vitro with the isolated human brain capillary preparation. The only amino acid that is albumin-bound is tryptophan, and the majority of albumin-bound tryptophan in the plasma is available for transport through the BBB via an enhanced dissociation mechanism that operates at the surface of the brain capillary endothelium. The availability in brain of amino acids is predicted from the BBB Km values to be sharply influenced by supra-physiological concentrations of phenyalanine in the 200-500 microM range. Moreover, the measurement of cerebral protein synthesis with an internal carotid artery perfusion technique and HPLC-based measurements of aminoacyl-transfer RNA specific activities shows an inverse relationship between cerebral protein synthesis and plasma phenyalanine concentrations in the 200-500 microM range. These findings indicate the neurotoxicity of hyperphenylalninemia is not restricted to the phenylketonuria range of approximately 2000 microM, but is exerted in the supra-physiological range of 200-500 microM.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9566601     DOI: 10.1023/a:1022482604276

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  33 in total

1.  The albumin receptor effect may be due to a surface-induced conformational change in albumin.

Authors:  R G Reed; C M Burrington
Journal:  J Biol Chem       Date:  1989-06-15       Impact factor: 5.157

Review 2.  Some special kinetic problems of transport.

Authors:  H N Christensen
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1969

3.  Measurement of brain uptake of radiolabeled substances using a tritiated water internal standard.

Authors:  W H Oldendorf
Journal:  Brain Res       Date:  1970-12-01       Impact factor: 3.252

4.  Transport of metabolic substrates through the blood-brain barrier.

Authors:  W M Pardridge; W H Oldendorf
Journal:  J Neurochem       Date:  1977-01       Impact factor: 5.372

5.  Kinetic constants for blood-brain barrier amino acid transport in conscious rats.

Authors:  L P Miller; W M Pardridge; L D Braun; W H Oldendorf
Journal:  J Neurochem       Date:  1985-11       Impact factor: 5.372

6.  Letter: Tryptophan and hepatic encephalopathy.

Authors:  W M Pardridge
Journal:  Lancet       Date:  1975-05-03       Impact factor: 79.321

Review 7.  Morphology of blood-brain interfaces.

Authors:  M W Brightman
Journal:  Exp Eye Res       Date:  1977       Impact factor: 3.467

8.  Kinetics of neutral amino acid transport across the blood-brain barrier.

Authors:  Q R Smith; S Momma; M Aoyagi; S I Rapoport
Journal:  J Neurochem       Date:  1987-11       Impact factor: 5.372

9.  Transport of tryptophan into brain from the circulating, albumin-bound pool in rats and in rabbits.

Authors:  W M Pardridge; G Fierer
Journal:  J Neurochem       Date:  1990-03       Impact factor: 5.372

10.  Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. A model for the study of phenylalanine and brain function in man.

Authors:  W Krause; M Halminski; L McDonald; P Dembure; R Salvo; D Freides; L Elsas
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

View more
  68 in total

1.  Evaluation of an in vitro coculture model for the blood-brain barrier: comparison of human umbilical vein endothelial cells (ECV304) and rat glioma cells (C6) from two commercial sources.

Authors:  J L Scism; D A Laska; J W Horn; J L Gimple; S E Pratt; R L Shepard; A H Dantzig; S A Wrighton
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999 Nov-Dec       Impact factor: 2.416

2.  Simultaneous analysis of plasma and CSF by NMR and hierarchical models fusion.

Authors:  Agnieszka Smolinska; Joram M Posma; Lionel Blanchet; Kirsten A M Ampt; Amos Attali; Tinka Tuinstra; Theo Luider; Marek Doskocz; Paul J Michiels; Frederic C Girard; Lutgarde M C Buydens; Sybren S Wijmenga
Journal:  Anal Bioanal Chem       Date:  2012-03-07       Impact factor: 4.142

Review 3.  Targeting the neurovascular unit for treatment of neurological disorders.

Authors:  Reyna L Vangilder; Charles L Rosen; Taura L Barr; Jason D Huber
Journal:  Pharmacol Ther       Date:  2010-12-21       Impact factor: 12.310

Review 4.  How to measure drug transport across the blood-brain barrier.

Authors:  Ulrich Bickel
Journal:  NeuroRx       Date:  2005-01

5.  Nutritional status in patients with phenylketonuria using glycomacropeptide as their major protein source.

Authors:  A Pinto; M F Almeida; P C Ramos; S Rocha; A Guimas; R Ribeiro; E Martins; A Bandeira; A MacDonald; J C Rocha
Journal:  Eur J Clin Nutr       Date:  2017-04-12       Impact factor: 4.016

6.  Differential effects of low-phenylalanine protein sources on brain neurotransmitters and behavior in C57Bl/6-Pah(enu2) mice.

Authors:  Emily A Sawin; Sangita G Murali; Denise M Ney
Journal:  Mol Genet Metab       Date:  2014-02-08       Impact factor: 4.797

Review 7.  Nutritional management of PKU with glycomacropeptide from cheese whey.

Authors:  D M Ney; S T Gleason; S C van Calcar; E L MacLeod; K L Nelson; M R Etzel; G M Rice; J A Wolff
Journal:  J Inherit Metab Dis       Date:  2008-10-29       Impact factor: 4.982

8.  Experimental evidence that phenylalanine provokes oxidative stress in hippocampus and cerebral cortex of developing rats.

Authors:  Carolina G Fernandes; Guilhian Leipnitz; Bianca Seminotti; Alexandre U Amaral; Angela Zanatta; Carmen R Vargas; Carlos S Dutra Filho; Moacir Wajner
Journal:  Cell Mol Neurobiol       Date:  2009-09-23       Impact factor: 5.046

9.  Branched-chain amino acids alter neurobehavioral function in rats.

Authors:  Anna Coppola; Brett R Wenner; Olga Ilkayeva; Robert D Stevens; Mauro Maggioni; Theodore A Slotkin; Edward D Levin; Christopher B Newgard
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-12-18       Impact factor: 4.310

Review 10.  Large neutral amino acids in the treatment of PKU: from theory to practice.

Authors:  Francjan J van Spronsen; Martijn J de Groot; Marieke Hoeksma; Dirk-Jan Reijngoud; Margreet van Rijn
Journal:  J Inherit Metab Dis       Date:  2010-10-26       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.